Its overexpression promotes the migration and invasion of HCC and LC cells through the PI3K/AKT signaling pathway, suggesting elongator-driven metastasis in LC relapse and drug resistance (Xu et al., 2018b). Here, AKT1 is linked to hepatocellular carcinoma.